Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
- Nat. Commun., Published: 03 July 2020, 11, Article number: 3288 (2020) | https://doi.org/10.1038/s41467-020-17139-y